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Previous reports have shown that elevated polyamine biosynthesis is sufficient to promote skin tumorigenesis
in susceptible mouse strains. We hypothesized that increased activity of epidermal ornithine decarboxylase
(ODC), a key regulatory enzyme in polyamine biosynthesis, may suppress the cutaneous immune response in
addition to stimulating proliferation. Using an ODCER transgenic mouse model in which ODC is targeted to the
epidermis, we examined the effect of ODC overexpression in keratinocytes on a classic contact hypersensitivity
(CHS) response. Compared with normal littermate mice, ODCER transgenic mice showed reduced ear swelling,
reduced neutrophil infiltration, and decreased migration of fluorescein isothiocyanate-loaded dendritic cells
(DCs) to draining lymph nodes following hapten elicitation of CHS. In addition, elevated epidermal ODC
activity suppressed the levels of cytokines keratinocyte-derived chemokine, monocyte chemoattractant protein-1,
interleukin-6 (IL-6), and IL-10. Adoptive transfer of lymphocytes from sensitized ODCER transgenic or normal
littermate mice to naive ODCER transgenic or wild-type mice indicated that elevated epidermal ODC activity
suppresses both the sensitization and elicitation phases of CHS. The specific ODC inhibitor, a-difluoromethy-
lornithine, abrogated all suppressive effects of ODC in CHS reactions. Collectively, these data suggest that the
immunosuppression promoted by increased epidermal ODC is mediated by a reduction in cytokine levels,
which suppresses DC migration and reduces immune cell infiltration to the site of hapten application.
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INTRODUCTION
Elevated polyamine biosynthesis is found in normal tissue
remodeling such as wound healing, and in pathogenic
conditions such as cancer (Tabor and Tabor, 1984; Pegg,
1986, 1988). Polyamines, including putrescine, spermidine,
and spermine, are some of the major cations present in all
cells. Ornithine decarboxylase (ODC), the initial rate-limiting
enzyme involved in polyamine biosynthesis, is responsible
for converting L-ornithine to putrescine. The induction of
ODC is a hallmark of tumor promoting activity (O’Brien,
1976; DiGiovanni, 1992), and targeted overexpression of
ODC in the epidermis has been shown to promote
carcinogenesis in susceptible mouse strains (Megosh et al.,
1995; O’Brien et al., 1997; Lan et al., 2005). The tumor
promoting activity of agents, such as 12-O-tetradecanoyl-
phorbol 13-acetate, is known to depend on both inflamma-
tory processes and hyperplasia (DiGiovanni, 1992).
However, although chronic inflammation can contribute to
tumor development, cancer immunoediting by integrated
innate and adaptive immune responses can either eliminate
tumors or promote tumor outgrowth. Early studies demon-
strated the association between the tumor promoting activity of
12-O-tetradecanoylphorbol 13-acetate and its analogs with their
ability to inhibit contact hypersensitivity (CHS) responses in
mice (Halliday et al., 1988; Kodari et al., 1991). Subsequent
studies have lent further support to the notion that immunosup-
pressive/immunomodulating properties of 12-O-tetradecanoyl-
phorbol 13-acetate have a relevant role in tumor promotion
(Coussens and Werb, 2002; Swann et al., 2008). It is not clear
what overexpression of ODC in the epidermis does to influence
cutaneous immune reactions, in addition to promoting cellular
proliferation and skin carcinogenesis.
Although it is well known that polyamines are essential for
cellular proliferation, little is known about their role in
modulating immune responses in vivo. Moreover, because
keratinocytes have an important role in modulating the
immune response, it is important to understand how elevated
polyamine biosynthesis in these cells may affect cutaneous
immune function. In vitro studies have shown that spermine
and spermidine inhibit lymphocyte proliferation and inter-
leukin-2 (IL-2) production through the reactive oxidation
species generated by polyamine catabolic oxidases; they
have also been shown to decrease macrophage-mediated
tumoricidal activity, neutrophil locomotion, and NK cell
activity, which is IL-2 dependent (Labib and Tomasi, 1981;
Ferrante et al., 1986; Chamaillard et al., 1993, 1997). These
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studies suggest that increased polyamine biosynthesis in the
microenvironment generally suppresses the function of innate
immunity. However, no studies have investigated the effect of
increased polyamine biosynthesis on an adaptive T-cell-
mediated immune response.
CHS, a classic delayed-type hypersensitivity reaction to
topically applied haptens, is a dendritic cell (DC)-dependent,
T-cell driven, cytokine-mediated skin inflammation (Eisen
et al., 1952; Xu et al., 1996). The mechanism of CHS can be
separated into two distinct phases, sensitization and elicita-
tion. During the sensitization phase, hapten binds covalently
to cell-associated or extracellular proteins in the skin to form
a hapten-carrier complex that is taken up by DCs that migrate
into T-cell-rich areas of skin-draining lymph nodes to present
hapten-MHC complexes to naive T cells (Kripke et al., 1990).
The T cells subsequently become activated and clonally
proliferate. The elicitation phase of CHS is initiated by
exposure of the same hapten to the skin. This subsequent
challenge with hapten results in an activation of hapten-
specific T cells and their recruitment to the site of contact.
CD8þ T cells that produce proinflammatory cytokines such
as IFN-g, IL-1, IL-6, and keratinocyte-derived chemokine (KC)
are the predominant effector cells that mediate CHS (Xu
et al., 1996). It is thought that induction of IL-4- and IL-10-
producing CD4þ T cells provides a protective role by dam-
pening response and preventing exuberant immunopathology
during the CHS response (Xu et al., 1996).
Here, we examined whether ODC overexpression targeted
to the epidermis influences the CHS response to the classic
contact sensitizer, oxazolone. Using transgenic mouse
models in which ODC is targeted to the epidermis, we show
that elevated epidermal ODC potently suppresses a hapten-
induced contact allergic response.
RESULTS
Increased ODC activity suppresses CHS
The contact sensitizer, oxazolone, was used to evaluate the
hypersensitivity response in ODCER and normal littermate
mice. Oxazolone-sensitized normal FVB mice exhibited a
robust CHS response with significant ear swelling on
subsequent challenge with oxazolone (Figure 1a). The
response was maximal at 24hours and began to return to
baseline within 72hours. In contrast, ODCER mice showed
little or no response when challenged with oxazolone during
the same time course. To evaluate changes in vascular
permeability associated with adaptive inflammatory responses,
a modified Miles assay was performed (Kunstfeld et al., 2004).
Challenge of previously sensitized normal mice with oxazo-
lone led to a significant increase in dye extravasation (Figure
1b). The amount of dye present in the ears of ODCER mice
was reduced by about 45%. No difference in dye extravasation
was observed when a nonspecific irritant, sodium dodecyl
sulfate, was used. These data indicate that the diminished ear
swelling response during the CHS reaction is due to a specific
repression of an inducible reaction but not due to the innate
response to general irritation.
Single-cell suspensions were prepared from ears 24 hours
after elicitation. Cells were analyzed by flow cytometry for
the presence of leukocytes on the basis of CD11b and Gr-1
staining. A significant number of CD11bþ Gr-1Hi cells, a
phenotype indicative for neutrophils, was present in the ears
of normal FVB mice following oxazolone elicitation; they
were drastically reduced in oxazolone-challenged ears of
ODCER transgenic mice (Figure 1c). No change was
observed in the percentage of CD11bþGr-1Lo/Mod cells
between ODCER and normal littermate mice at the same
time point (7.4±1.96% vs. 7.5±1.8%, respectively). The
vehicle control-treated ears from both ODCER and normal
FVB mice had no leukocyte infiltration. Immunohistochem-
ical staining of oxazolone-challenged ears from normal mice
exhibited strong immunoreactivity when stained with a
neutrophil-specific antibody (Figure 1d). In contrast, oxazo-
lone-challenged ears obtained from ODCER mice showed
reduced neutrophil infiltration. Together, these data suggest
an immunosuppressive role for increased epidermal ODC
activity during oxazolone elicitation of CHS.
Elevated epidermal ODC activity suppresses the sensitization
and elicitation phase of CHS
To show the dependence of CHS suppression on epidermal
polyamine biosynthesis, a specific inhibitor of ODC activity,
a-difluoromethylornithine (DFMO), was used. To determine
the effect of elevated ODC activity on the sensitization
phase of the CHS response, ODCER mice were treated with
4-hydroxytamoxifen for 2 weeks and subsequently sensitized
to oxazolone. Around 5 days later, normal and ODCER mice
were placed on DFMO for 4 days. The mice were elicited on
day 9 after sensitization and the ear swelling response was
determined (Figure 2a). Elevated ODC activity during the
sensitization phase inhibited the CHS response. To deter-
mine the effect of ODC overexpression during the elicitation
phase of the CHS response, ODCER mice were sensitized
to oxazolone, while on DFMO, to inhibit any basal ODC
activity, and before 4-hydroxytamoxifen induction of enzyme
activity. Around 3 days after sensitization, DFMO treatment
was withdrawn and epidermal ODC activity was induced by
topical application of 4-hydroxytamoxifen (Lan et al., 2005).
After 4 days of ODC induction, the mice were challenged
with oxazolone. Elevated ODC activity during the elicitation
phase was capable of suppressing oxazolone-induced CHS
(Figure 2b). To reverse the ODC-mediated immunosuppres-
sion of CHS response to oxazolone, K6/ODC mice were
administered 1% DFMO through their drinking water for the
duration of the CHS protocol (Figure 2c). K6/ODC transgenic
mice treated with DFMO showed a significant CHS response
to oxazolone, similar to the level observed in non-treated
wild-type littermates. There was a slight decrease in ear
swelling in normal mice administered DFMO; however, the
response was still significantly greater than in K6/ODC
transgenic mice given tap water. These data demonstrate
that elevated epidermal ODC activity is sufficient to suppress
either the sensitization phase or the elicitation phase of CHS.
As the CHS response is dependent on both the sensitization
and elicitation phases, DFMO inhibition of ODC activity is
only effective in reversing the suppression when administered
throughout the CHS protocol.
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Direct injection of immune effectors into the ear, but not
intravenous adoptive transfer, restores CHS in ODCER mice
To determine the effect of elevated epidermal ODC activity
on the ability to adoptively transfer CHS, donor lymphocytes
were obtained from oxazolone-sensitized ODCER transgenic
mice and their normal littermates. Recipient naive mice,
either ODCER or normal littermates, received 2 107 cells
intravenously. Normal recipient mice receiving cells from
normal sensitized mice showed oxazolone-induced ear
swelling 24 hours after challenge (Figure 3a). In contrast,
ODCER recipients of normal donor lymphocytes showed no
hapten-driven ear swelling. No significant ear swelling was
observed in either group of recipient mice, ODCER or normal
littermates, which received ODCER donor lymphocytes. These
data corroborate findings from our studies with DFMO,
indicating that elevated epidermal ODC activity suppresses both
the sensitization and elicitation phases of the CHS response.
A number of investigations have demonstrated that a lack
of CHS response may be overcome by directly delivering
effector cells to the site of elicitation (Biedermann et al.,
2000; Engeman et al., 2004; Grimbaldeston et al., 2007). The
decreased immune cell infiltration into the elicited ears of
ODCER transgenic mice was addressed by intradermally
injecting lymphocytes isolated from the auricular draining
lymph nodes of elicited normal or ODCER mice. Intradermal
injection of 1 106 lymphocytes from ODCER mice was
sufficient to restore the CHS response in sensitized ODCER
mice (Figure 3b). These data, in contrast to the adoptive
transfer data using naive recipients, demonstrate that
lymphocytes from ODCER transgenic mice are capable of
mediating a hypersensitivity response when delivered directly
to the challenged site.
Altered DC migration and fluorescein isothiocyanate
(FITC)-induced CHS in ODCER transgenic mice
To track the migration of DCs in vivo, the ears of ODCER and
normal littermate mice were painted with FITC; after
36 hours, draining lymph nodes were harvested and analyzed
for the presence of CD11cþMHCIIþFITCþ DC by flow
cytometry. The auricular draining lymph nodes from FITC-
treated normal FVB mice showed a significantly greater
number of CD11cþMHCIIþFITCþ cells (Figure 4a) when
compared with ODCER mice. No difference in expression of
costimulatory molecules, CD80 or CD86, was detected in
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Figure 1. Elevated epidermal ODC activity suppresses oxazolone-induced contact hypersensitivity. (a) Hapten-specific ear swelling was measured at 24-hour
intervals for 3 days after elicitation. The results represent the mean swelling response±SD. (b) Vascular permeability was analyzed using a modified Miles assay
24 hours after oxazolone elicitation or 4 hours after sodium dodecyl sulfate treatment. The graph represents the average amount of extravasated Evans blue dye
(EBD)±SD (c) Single-cell suspensions of ear tissue were stained 24 hours after elicitation for the infiltration of neutrophils. The graph represents the average
percentage of positive events per group±SD. (d) Immunohistochemistry of vehicle treated and oxazolone-challenged ear tissue from ODCER and normal
littermate mice stained with an antineutrophil antibody. Scale bar¼50 mm. *Pp0.05 vs. normal group.
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FITC-positive DCs that had migrated to the draining lymph
node on the hapten-treated side (data not shown). A similar
number of CD11cþMHCIIþ cells was present in the vehicle-
treated skin and draining lymph nodes of ODCER mice when
compared with normal littermate mice, indicating that the
migratory defect was not due to a change in the number of
resident DCs (data not shown). In conjunction with the
increased numbers of FITC-positive cells, the intensity of FITC
fluorescence in the migrated DC population was significantly
greater in normal FVB mice when compared with ODCER
mice (Figure 4b). In addition, ODCER mice showed a
diminished ear swelling response when FITC was used as a
contact sensitizer (Figure 4c). These data suggest that
elevated ODC activity in the epidermis impairs DC migration
during hapten sensitization and the inhibition of the CHS
response is not hapten specific.
Elevated epidermal ODC activity suppresses inflammatory
cytokines during sensitization
The ears of ODCER and normal littermate mice were
sensitized to oxazolone; after 24 hours, the ears were
removed, homogenized, and supernatants were analyzed
for the presence of inflammatory cytokines by flow cytome-
try. A significant decrease in the levels of KC, monocyte
chemoattractant protein-1 (MCP-1), and IL-6 was observed in
ODCER mice 24 hours after sensitization with oxazolone
(Figure 5a).
Next, lymphocytes isolated from the draining lymph nodes
24 hours after elicitation were stimulated ex vivo and
analyzed for cytokine expression. Following 18 hours of
ex vivo stimulation, lymphocytes isolated from normal mice
showed significantly greater levels of IL-10 and IL-6 in
comparison with lymphocytes from ODCER mice (Figure 5b).
Primary keratinocytes were isolated from neonatal K6/
ODC transgenic and normal littermate mice to analyze the
contribution of cytokine expression from keratinocytes.
Conditioned media were collected from primary keratino-
cytes after 36 hours in culture and subsequently analyzed for
the levels of cytokines. A significant amount of MCP-1 was
present in the conditioned media of normal primary
keratinocyte cultures in comparison with K6/ODC primary
keratinocyte cultures (Figure 5c). Together with the whole
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Figure 2. Elevated ODC suppresses the sensitization and elicitation phase of CHS. ODCER (a and b) or K6/ODC (c) were subjected to a CHS regimen
using oxazolone, as illustrated by the time lines adjacent to each graph. During various stages of the CHS protocol, mice were administered 1%
a-difluoromethylornithine (DFMO), the ODC-specific inhibitor, through their drinking water. (a) DFMO treatment was used to inhibit ODC activity during
elicitation. (b) DFMO treatment for 3 days before 4OHT induction of epidermal ODC activity. (c) DFMO during the sensitization and elicitation phases of
oxazolone-induced CHS in K6/ODC mice and normal littermates. Graphs show the change in ear swelling response 24 hours after elicitation±SD. *Pp0.05 vs.
the normal group. 4OHT, 4-hydroxytamoxifen.
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tissue and lymphocyte cytokine data, this result indicates that
elevated epidermal ODC activity promotes reduced cytokine
secretion by different cell types involved in host response to
hapten stimulation.
DISCUSSION
This study shows that elevated ODC activity in keratinocytes
suppresses a classic hapten-induced CHS immune response
that is dependent on cytokine expression following hapten
application. The central role of cytokines during this
cutaneous immune response to reactive haptens has been
demonstrated in a number of studies. For instance, MCP-1-
deficient mice have a normal ear swelling response but
diminished immune cell infiltration during the elicitation
phase of CHS (Lu et al., 1998). Mice treated with a
neutralizing antibody against KC/CXCL1 exhibit an impaired
CHS response (Dilulio et al., 1999). In addition, mice lacking
the KC receptor, CXCR2, have an impaired CHS response that
is directly attributable to reduced neutrophil infiltration
(Cattani et al., 2006). Moreover, IL-6-deficient mice fail to
respond to hapten challenge because of impaired DC
migration (Nishimura et al., 1999). In this study, elevated
epidermal ODC activity leads to decreased levels of MCP-1,
KC/CXCL1, and IL-6 in the ears of oxazolone-treated mice,
and primary cultures of ODC overexpressing keratinocytes
express less MCP-1. During the elicitation phase, fewer
neutrophils are present in the ears of ODCER mice when
compared with their normal littermates. Finally, hapten-
stimulated DC migration to regional lymph nodes is impaired
in mice with elevated epidermal ODC activity. Collectively,
these data demonstrate that elevated ODC activity in
keratinocytes prevents the expression of key cytokines
required for immune cell recruitment and DC migration
following hapten stimulation.
The induction of CHS is dependent on DC and T-cell
activation. The central role of dermal dendritic and Langerhans
cells in the elicitation of this cutaneous immune response to
reactive haptens has been demonstrated in a number of
studies. Ablation or inhibition of migration of these resident
antigen presenting cells leads to suppression/attenuation of
the CHS response (Bennett et al., 2005; Wang et al., 2009). In
contrast, increased mobilization of DC in response to
haptens, as in IL-10 knockout mice, has been shown to
exacerbate the CHS response (Wang et al., 1999). DC
migration and function are dependent on cross-talk with
epidermal keratinocytes as well. For instance, the interaction
of keratinocytes and DC can modulate the host response to
contact sensitizers to prevent deleterious inflammatory
reactions (Kim et al., 2009). We have shown that elevated
epidermal ODC activity inhibits the migration of DC to local
lymph nodes after topical application of FITC. Oxazolone-
sensitized lymphocytes from ODCER mice fail to elicit a CHS
response when adoptively transferred to naive normal
littermate mice. Moreover, lymphocytes from hapten-sensi-
tized normal mice are unable to elicit a CHS response in
naive ODCER mice on adoptive transfer. However, the
overall competency of lymphocytes does not seem to be
altered, given that intradermal injection of primed lympho-
cytes into sensitized ODCER transgenic recipients restores
the CHS response. These data collectively point to a
diminished DC function mediated by elevated epidermal
ODC activity. Studies are underway to investigate mechan-
isms by which elevated epidermal ODC activity suppresses
the effective priming of CD8þ T cells following hapten
challenge and during skin tumorigenesis.
Polyamines have been shown to have immunomodulatory
effects on immune cells (Chamaillard et al., 1993, 1997), and
treatment with exogenous spermine has a protective role in a
murine model of bacterial sepsis characterized by a reduction
in the peritoneal and serum levels of IL-6, KC, and MCP-1
(Zhu et al., 2009). Following ODC enzyme induction,
elevated levels of putrescine are observed in the epidermis
of ODCER mice with no detectable change in spermine or
spermidine (Lan et al., 2005). In this study, elevated
epidermal ODC activity suppresses the expression of IL-6,
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Figure 3. Intradermal injection of oxazolone-sensitized lymphocytes
restores CHS response in ODCER mice. (a) Donor lymphocytes from
sensitized normal or ODCER mice were adoptively transferred intravenously
into naive ODCER or normal littermate recipients as indicated. At 12 hours
after transfer, the recipient mice were elicited on the right ear with oxazolone.
At 24 hours after elicitation, the CHS response was determined by measuring
ear thickness. (b) Lymphocytes from oxazolone-elicited draining lymph nodes
of donor mice were harvested and injected intradermally into sensitized
recipient mice. Immediately after injection, the ears were elicited with
oxazolone. The CHS response was determined 24hours after elicitation.
Graphs represent the average ear swelling response±SD. *Pp0.05 compared
with (a) the normal:normal group and (b) the normal group.
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MCP-1, and KC, as was reported in the bacterial sepsis
model. This finding suggests that high levels of putrescine
present in the epidermis of ODCER mice are sufficient to
suppress the inflammatory response to contact sensitizers.
The current study has demonstrated an immunosuppres-
sive role for elevated epidermal ODC activity during a
cutaneous hypersensitivity response in ODC transgenic mice.
Our data suggest that this suppressive effect on a hapten-
induced CHS response is dependent, at least in part, on
effects of ODC-overexpressing keratinocytes on antigen
presenting DC function that is essential for T-cell activation
in this adaptive immune response. Immunosuppressive
responses are quite beneficial when suppressing the inflam-
matory response to environmental stimuli. However, the
suppressive environment may provide a setting for immune
escape of developing cutaneous tumors.
MATERIALS AND METHODS
Mice
The mouse lines used for this study were (1) ODCER transgenic
mice, in which the suprabasal expression of ODC activity is driven
by the human involucrin promoter upstream of the murine ODC
gene fused to a modified estrogen receptor binding domain (Lan
et al., 2005), and (2) K6/ODC transgenic mice, in which the keratin-6
promoter targets constitutive expression of ODC to the outer root
sheath of the hair follicle (Megosh et al., 1995). All mice used for
these experiments were on the FVB background. In all experiments
using inducible ODCER mice, both ODCER mice and their normal
littermates were topically treated daily on their shaved dorsal skin
with 4-hydroxytamoxifen (0.1mg100ml1 ethanol) beginning at
6 weeks of age to induce ODC activity (Lan et al., 2005). All animal
experiments were conducted under the approval of the Institutional
Animal Care and Use Committee of the Lankenau Institute for
Medical Research. Where indicated, mice were administered 1%
DFMO (w/v) in their drinking water. All experiments were repeated
using at least three mice per group.
CHS to oxazolone
Mice were sensitized on their shaved abdomen (50 ul) and hind
footpads (5 ul) with 3% oxazolone (Sigma, St Louis, MO). Around
5days later, sensitized mice were anesthetized with isoflurane, each
ear was measured using a dial thickness gauge (Fowler, A&M
Industrial Supply, Rahway, NJ), and then the right ear was topically
challenged with 20 ml of 1% oxazolone, with 10 ml on each side. The
left ear was treated with vehicle alone, 100% ethanol, in a similar
manner. The increase in ear thickness was calculated by subtracting
left (vehicle) ear thickness from right (treated) ear thickness.
Preparation of single-cell suspensions from the ear
The ears were excised and digested by incubation with 0.3%
collagenase per 0.1% hyaluronidase solution at 37 1C for 1.5 hours,
followed by gentle trituration. The cell suspension was passed
through a nylon mesh filter, the cells pelleted, and then suspended in
fluorescent-activated cell sorting buffer for flow cytometric analysis.
Vascular permeability assessment with Evans blue dye
Around 2 hours before challenge with 1% oxazolone or 10% sodium
dodecyl sulfate on the ears, mice were injected intravenously with
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100ml of 5mgml1. Evans blue dye (Sigma) in phosphate-buffered
saline. At the peak of inflammation, that is, at either 24 hours
(Oxazolone) or 4 hours (sodium dodecyl sulfate) (Mizumoto et al.,
2003), mice were killed and ears were removed, dried for 6 hours at
56 1C, weighed, minced, and the dye was extracted with 1ml of
formamide for 24 hours at 55 1C. Samples were filtered to remove
tissue debris and OD620 was measured to assess the content of the
extravasated dye on the basis of a standard curve of Evans blue dye.
Vascular leakage specific for CHS was determined as the content
of Evans blue dye per milligram of dried tissue found in the
oxazolone or sodium dodecyl sulfate-painted ear (induced) minus
the background value determined for the control ear of the same
animal (spontaneous).
In vivo DC migration and CHS to FITC
FITC was dissolved in dibutylphthalate:acetone (1:1) at 5mgml1.
ODCER mice and their normal littermates received 20 ml of the
FITC solution, 10 ml on the ventral and dorsal sides of the ear. After
36 hours, the mice were killed and draining lymph nodes were
dissected to analyze for the presence of FITC-positive cells. Single-
cell suspensions were prepared by incubating the lymph nodes in a
1% collagenase per 0.01mgml1 DNase I solution at 37 1C for
30minutes, followed by pressing the tissue through a nylon mesh
filter. Migrating DCs were identified as CD11cþMHCIIþFITCþ cells
using flow cytometry, and 5 105 events were acquired for each
lymph node. For the CHS reaction, the abdomen was sensitized
(400ml) and the ears challenged (20 ml) 6 days later with FITC.
Cytokine bead array analysis
Naive ODCER and normal littermate mice were treated with a
sensitizing dose of oxazolone on the right ear; the left ear received
vehicle alone. After 24 hours, the mice were killed and the ears
removed for cytokine analysis. Ear tissue was homogenized in
phosphate-buffered saline with protease inhibitors and dithio-
threitol. The debris was cleared by centrifugation and supernatants
were analyzed using Cytometric Bead Array reagents (BD Biosciences,
San Jose, CA) as per the manufacturer’s protocol.
Draining lymph nodes from elicited ears were dissected free and
single-cell suspensions were prepared for ex vivo stimulation with
PMA and ionomycin. Lymphocytes, 1 106ml1, were cultured in
RPMI 1640 with or without TPA (50 ngml1) and ionomycin
(250 ngml1) for 18 hours. The supernatants were cleared of debris
by centrifugation and cytokine analysis was performed using flow
cytometry as above. Keratinocyte cultures were prepared as
described (Wei et al., 2008).
Flow cytometry
Equal numbers of viable cells from total skin or draining lymph
nodes were stained with combinations of the following: FITC-
conjugated rat anti-Gr-1, (RB6-8C5, recognizing Ly-6C and Ly-6G
antigens), PE-conjugated rat anti-CD11b (M1/70), PE-conjugated rat
anti-MHC class II (M5/114.15.2IA), PerCP-Cy7-conjugated CD11c
(N418), PE-Cy5-conjugated Armenian hamster anti-CD80 (clone
16-10A1), or APC-conjugated rat anti-CD86(clone Gl-1). All
antibodies were from eBioscience (San Diego, CA). Stained cells
were analyzed on a BD FACSCanto II cytometer using FACSDiva
software (BD Biosciences) or FloJo7 software (Tree Star, Ashland,
OR). Viable cells were gated on the basis of forward and side scatter
profiles. A minimum of 10,000 events were analyzed for each
condition.
Immunohistochemistry
Ears were fixed in 4% paraformaldehyde at room temperature,
followed by embedding in paraffin. Skin sections were deparaffi-
nized, hydrated, and then heated in 0.01 M sodium citrate buffer (pH
6.0). Sections were incubated with a rat antimouse neutrophil
antibody recognizing the 7/4 antigen (Clone 7/4, Cedarlane,
Burlington, NC), followed by treatment with the biotinylated
secondary antibody and then with an avidin horseradish peroxidase
complex (Vectastain Elite ABC kit, Vector Laboratories, Burlingame,
CA). A control section was treated in a similar manner, with the
exception of incubation with the primary antibody. Immunoreactive
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Figure 5. Reduced cytokine levels in ODCER transgenic mice after
sensitization with oxazolone. The levels of indicated proinflammatory
cytokines were measured using cytometric bead assays on (a) whole-tissue
homogenates of oxazolone-sensitized ear skin from normal and ODCER mice
24hours after application, (b) cell culture supernatants from 1106
lymphocytes from auricular lymph nodes isolated 24 hours after elicitation
and cultured ex vivo for 18 hours without () or with (þ ) PMA and
ionomycin, and (c) conditioned medium from primary keratinocyte cultures
from neonatal K6/ODC mice or normal littermate skin after 36 hours in
culture. The graph represents the average pg/ml of each ligand±SD. *Pp0.05
vs. normal.
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cells were localized by incubating sections with a chromagen
solution containing diaminobenzidine and peroxide and then
counterstaining with hematoxylin. Pictures were acquired using
a Zeiss Axiophot microscope with a digital color camera and
corresponding Axiocam software (Carl Zeiss, Oberkochen, Germany).
All images were processed for printing using Adobe Photoshop
software (Adobe Systems, San Jose, CA).
Adoptive transfer of lymphocytes
Donor mice, both ODCER transgenic and normal littermates, were
sensitized to oxazolone. After 5 days, peripheral lymph nodes and
spleens were harvested, and single-cell suspensions were prepared
by pressing the tissues through a nylon mesh filter with a syringe
plunger. Red blood cells were removed by lysis in NH4Cl buffer, and
the remaining cells washed extensively in phosphate-buffered saline
and labeled with carboxy fluorescein succimidyl ester. Naive recipient
animals received 2 107 carboxy fluorescein succimidyl ester-labeled
cells by intravenous injection through the retro-orbital sinus. The recipient
mice were challenged on the right ear with 1% oxazolone 12hours after
adoptive transfer. The CHS response was monitored by determining
the change in ear thickness 24 hours after oxazolone challenge. Equal
numbers of carboxy fluorescein succimidyl ester-labeled cells were
detected in the draining lymph nodes of all recipient mice.
For intradermal injections, auricular draining lymph nodes were
isolated from elicited ODCER or normal littermate mice 24hours after
hapten challenge. Single-cell suspensions were prepared by pressing
the tissue through a mesh filter. Cells were suspended at 2 107 cells
per ml in sterile phosphate-buffered saline and 50ml was injected into
the pinna of the right ear of a sensitized recipient. Immediately after
injection, the ears were challenged with 1% oxazolone. Ear measure-
ments were determined 24hours after elicitation.
Statistics
Student’s t-test was used to evaluate the significance of the data.
A P-value p0.05 was considered significant.
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